1 |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2021[J]. CA A Cancer J Clin, 2021, 71(1): 7-33.
|
2 |
LI J, LI Y J, WANG B, et al. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway[J]. J Biomed Sci, 2017, 24(1): 95.
|
3 |
BLANDIN KNIGHT S, CROSBIE P A, BALATA H, et al. Progress and prospects of early detection in lung cancer[J]. Open Biol, 2017, 7(9): 170070.
|
4 |
TSILIMIGRAS D I, NTANASIS-STATHOPOULOS I, MORIS D, et al. Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective[J]. Surg Oncol, 2018, 27(4): 611-618.
|
5 |
SALIMI V, SHAHSAVARI Z, SAFIZADEH B,et al. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment[J]. Lipids Health Dis, 2017, 16(1): 208.
|
6 |
CALCAGNO D Q, WISNIESKI F, MOTA E R D S, et al. Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives[J]. Epigenomics, 2019, 11(3): 349-362.
|
7 |
WANG F F, WU H S, FAN M J, et al. Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells[J]. FASEB J, 2020, 34(3): 4266-4282.
|
8 |
KAZEMI SEFAT N A, MOHAMMADI M M, HADJATI J, et al. Sodium butyrate as a histone deacetylase inhibitor affects toll-like receptor 4 expression in colorectal cancer cell lines[J]. Immunol Invest, 2019, 48(7): 759-769.
|
9 |
JIA X Y, ZHENG Y S, GUO Y Z, et al. Sodium butyrate and panobinostat induce apoptosis of chronic myeloid leukemia cells via multiple pathways[J]. Mol Genet Genomic Med, 2019, 7(5): e613.
|
10 |
XIAO X Q, XU Y X, CHEN H Y. Sodium butyrate-activated TRAF6-TXNIP pathway affects A549 cells proliferation and migration[J].Cancer Med,2020,9(10): 3477-3488.
|
11 |
李官虎, 郎庆旭, 刘纯岩, 等. 丁酸钠联合X射线照射对肺癌A549细胞增殖的抑制作用及其对细胞周期的影响[J].吉林大学学报(医学版),2021,47(1): 152-157.
|
12 |
PANT K, YADAV A K, GUPTA P, et al. Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells[J]. Redox Biol, 2017, 12: 340-349.
|
13 |
SEMAAN J, EL-HAKIM S, IBRAHIM J N, et al. Comparative effect of sodium butyrate and sodium propionate on proliferation, cell cycle and apoptosis in human breast cancer cells MCF-7[J]. Breast Cancer, 2020, 27(4): 696-705.
|
14 |
EMANUELE S, LAURICELLA M, TESORIERE G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review)[J].Int J Oncol,2008,33(4): 637-646.
|
15 |
RÜCKERT F, SAMM N, LEHNER A K, et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis[J]. BMC Cancer, 2010, 10: 379.
|
16 |
姜贻乾,郭庆敏,朱春兰,等. miR-1269a表达对H460干细胞样细胞放疗敏感性的影响[J]. 解放军医学杂志,2020,45(9): 922-928.
|
17 |
NATONI F, DIOLORDI L, SANTONI C, et al. Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways[J].Biochim Biophys Acta,2005,1745(3): 318-329.
|
18 |
ZHANG L, CHENG X, GAO Y Y, et al. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells[J]. Food Funct, 2016, 7(1): 315-325.
|
19 |
LOUIS M, ROSATO R R, BRAULT L, et al. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress[J]. Int J Oncol, 2004, 25(6): 1701-1711.
|
20 |
BHAT A H, DAR K B, ANEES S, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight[J]. Biomedecine Pharmacother, 2015, 74: 101-110.
|
21 |
MCILWAIN D R, BERGER T, MAK T W. Caspase functions in cell death and disease[J]. Cold Spring Harb Perspect Biol, 2013, 5(4): a008656.
|
22 |
CHEN M J, JIANG W, XIAO C C, et al. Sodium butyrate combined with docetaxel for the treatment of lung adenocarcinoma A549 cells by targeting Gli1[J]. Onco Targets Ther, 2020, 13: 8861-8875.
|
23 |
MOERTL S, PAYER S, KELL R, et al. Comparison of radiosensitization by HDAC inhibitors CUDC-101 and SAHA in pancreatic cancer cells[J]. Int J Mol Sci, 2019, 20(13): 3259.
|
24 |
PERONA M, THOMASZ L, ROSSICH L, et al. Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid[J]. Mol Cell Endocrinol, 2018, 478: 141-150.
|